i-R474DsM-X3

The endovascular performance company

 

Solutions that remove proficiency barriers

We passionately develop endovascular simulation solutions to improve productivity and increase patient safety. For more than 20 years, our solutions have helped doctors acquire, retain, and enhance their endovascular therapy skills helping them improve patient outcomes. Our solutions are scientifically validated and are being extensively used around the world by teaching entities, healthcare systems, and medical device manufacturers alike. Join the revolution.

 

 

Medical Simulators

The Mentice VIST® platform includes portable high-fidelity endovascular simulators enabling hands-on procedural training.

Learn more >

VistG5_0020_frilagd-screens-full-CMYK-AIS
 

Product Highlight

The newest platform for endovascular simulation is here 👇

VIST® G7 & G7+ >

Coronary Advanced >

VIST_G7+_001
 

Customer Spotlight

Learn how the Neuroradiology Department at the Technical University Munich (TUM) apply simulation into their daily practice to improve operational performance and patient outcomes.

Learn more >

Prof Zimmer

years of experience pioneering interventional simulation.

scientific papers reinforcing the value of simulation skills acquisition, retention, and assessment.

medical simulation patents across >30 training procedures.

%

of global market share in endovascular simulation solutions.

 

Latest News

2 min read

Mentice Expands its Coronary Product Portfolio with an Advanced Software Solution for Coronary Interventions

Coronary Advanced to Help Fellows and Attending Interventional Cardiologists to Perfect Skills in...

12 min read

Mentice Launches Seventh Generation Platform Aimed to Transform Endovascular Therapy

VIST® G7 Introduces a Virtual Patient to Help Doctors AcquireRetain, and Enhance Skills in the...

2 min read

Mentice expands Coronary Product Portfolio with the introduction of Coronary Intermediate software

Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies,...

Don't go just yet!

Enter your email below to subscribe to Mentice updates.